股票行情快报：英科医疗（300677）2月5日主力资金净卖出451.11万元

Core Viewpoint - As of February 5, 2026, Yingke Medical (300677) closed at 40.94 yuan, experiencing a slight decline of 0.46% with a trading volume of 57,100 hands and a transaction amount of 233 million yuan [1] Financial Performance - For the first three quarters of 2025, Yingke Medical reported a main revenue of 7.425 billion yuan, an increase of 4.6% year-on-year; net profit attributable to shareholders was 924 million yuan, up 34.47% year-on-year; however, the net profit excluding non-recurring items decreased by 19.32% to 484 million yuan [2] - In Q3 2025, the company recorded a single-quarter main revenue of 2.511 billion yuan, down 2.9% year-on-year; single-quarter net profit attributable to shareholders was 214 million yuan, an increase of 113.04% year-on-year; single-quarter net profit excluding non-recurring items was 84.28 million yuan, down 25.87% year-on-year [2] - The company's debt ratio stands at 53.79%, with investment income of 183 million yuan and financial expenses of 127 million yuan; the gross profit margin is reported at 23.7% [2] Market Sentiment - Over the last 90 days, six institutions have provided ratings for the stock, with five giving a "buy" rating and one an "increase" rating [3]